Back to Search
Start Over
Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System.
- Source :
-
Applied health economics and health policy [Appl Health Econ Health Policy] 2020 Feb; Vol. 18 (1), pp. 57-68. - Publication Year :
- 2020
-
Abstract
- Objective: To perform a cost-utility analysis of diabetic retinopathy (DR) screening strategies from the perspective of the Brazilian Public Healthcare System.<br />Methods: A model-based economic evaluation was performed to estimate the incremental costs per quality-adjusted life-year (QALY) gained between three DR screening strategies: (1) the opportunistic ophthalmology referral-based (usual practice), (2) the systematic ophthalmology referral-based, and (3) the systematic teleophthalmology-based. The target population included individuals with type 2 diabetes (T2D) aged 40 years, without retinopathy, followed over a 40-year time horizon. A Markov model was developed with five health states and a 1-year cycle. Model parameters were based on literature and country databases. One-way and probabilistic sensitivity analyses were performed to assess model parameters' uncertainty. WHO willingness-to-pay (WHO-WTP) thresholds were used as reference (i.e. one and three times the Brazilian per capita Gross Domestic Product of R$32747 in 2018).<br />Results: Compared to usual practice, the systematic teleophthalmology-based screening was associated with an incremental cost of R$21445/QALY gained ($9792/QALY gained). The systematic ophthalmology referral-based screening was more expensive (incremental costs = R$4) and less effective (incremental QALY = -0.012) compared to the systematic teleophthalmology-based screening. The probability of systematic teleophthalmology-based screening being cost-effective compared to usual practice was 0.46 and 0.67 at the minimum and the maximum WHO-WTP thresholds, respectively.<br />Conclusion: Systematic teleophthalmology-based DR screening for the Brazilian population with T2D would be considered very cost effective compared to the opportunistic ophthalmology referral-based screening according to the WHO-WTP threshold. However, there is still a considerable amount of uncertainty around the results.
- Subjects :
- Adult
Aged
Aged, 80 and over
Brazil
Female
Humans
Male
Mass Screening statistics & numerical data
Middle Aged
Ophthalmology statistics & numerical data
State Medicine economics
State Medicine statistics & numerical data
Cost-Benefit Analysis
Diabetes Mellitus, Type 2 complications
Diabetes Mellitus, Type 2 economics
Diabetic Retinopathy diagnosis
Diabetic Retinopathy economics
Mass Screening economics
Ophthalmology economics
Subjects
Details
- Language :
- English
- ISSN :
- 1179-1896
- Volume :
- 18
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Applied health economics and health policy
- Publication Type :
- Academic Journal
- Accession number :
- 31674001
- Full Text :
- https://doi.org/10.1007/s40258-019-00528-w